3.74
0.19 (5.35%)
0.19 (5.35%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.19 | 5.35% | 3.74 | 18:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.55 | 3.55 | 3.78 | 3.74 | 3.55 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.55 | 3.84 | 0.29 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,640 | 737,724 | $ 3.66 | $ 2,702,710 | 328,651 | 0.93 - 5.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:50:50 | 20 | $ 3.80 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 48.68M | 13.02M | 6.45M | $ 1.11M | $ - | -0.23 | -17.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.91 | 3.96 | 3.49 | 3.66 | 183,471 | -0.17 | -4.35% |
| 1 Month | 2.98 | 4.30 | 2.94 | 3.64 | 368,668 | 0.76 | 25.5% |
| 3 Months | 2.51 | 4.30 | 2.3801 | 3.20 | 312,274 | 1.23 | 49.0% |
| 6 Months | 2.71 | 5.43 | 1.62 | 3.10 | 1,466,960 | 1.03 | 38.01% |
| 1 Year | 1.28 | 5.43 | 0.93 | 3.27 | 1,350,755 | 2.46 | 192.19% |
| 3 Years | 4.005 | 5.43 | 0.50 | 3.22 | 466,905 | -0.265 | -6.62% |
| 5 Years | 3.41 | 5.55 | 0.50 | 3.43 | 361,545 | 0.33 | 9.68% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
